B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages

B cell maturation antigen (BCMA), a transmembrane glycoprotein member of the tumor necrosis factor receptor superfamily 17 (TNFRSF17), highly expressed on the plasma cells of Multiple myeloma (MM) patients, as well as the normal population. BCMA is used as a biomarker for MM. Two members of the TNF...

Descripción completa

Detalles Bibliográficos
Autores principales: Nobari, Shirin Teymouri, Nojadeh, Jafar Nouri, Talebi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832753/
https://www.ncbi.nlm.nih.gov/pubmed/35144648
http://dx.doi.org/10.1186/s12967-022-03285-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832753/
https://www.ncbi.nlm.nih.gov/pubmed/35144648
http://dx.doi.org/10.1186/s12967-022-03285-y

Ejemplares similares